Sort
17,288 grants matching “multiple sclerosis”
T cell regulation by dendritic cells in EAE
$172,606Gregory Wu · University Of Pennsylvania · K08 · FY2008 · NS
Novel biochemical and functional targets of PARP
$172,599Mark R. Boothby · Vanderbilt University Medical Center · R21 · FY2015 · AI
Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
$172,584Heather M Burke · University Of California, San Francisco · K08 · FY2010 · MH
Causal Gene Prioritization in Systemic Sclerosis: Multi-Omics Analyses from Population Genetics to Single Cell Biology
$172,584Yiming Luo · Columbia University Health Sciences · K23 · FY2025 · AR
Investigating Correlates and Therapeutics of Fatigue
$172,552Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2018 · NR
Core D - Neuropathology, Genetics, and Biomarker Core
$172,515John Q. Trojanowski · University Of Pennsylvania · P30 · FY2017 · AG
MOLECULAR GENETICS OF AUTISM
$172,411Yale University · P01 · FY2001 · HD
OLIGODENDROCYTE GENERATION--A MULTIFACTORIAL APPROACH
$172,328Pennsylvania State Univ Hershey Med Ctr · R01 · FY2001 · NS
Novel Technologies for Investigation of Self-reactive T cells in MS and Relevant
$172,313John Christopher Love · Dana-Farber Cancer Inst · P01 · FY2017 · AI
Extracellular matrix regulation of myelination
$172,250Holly A Colognato · State University New York Stony Brook · R01 · FY2009 · NS
PATHOGENESIS OF DEMYELINATION IN MS BRAINS
$172,216Cleveland Clinic Foundation · R01 · FY2000 · NS
Assay Development for Drugs to Reduce Neuroinflammation
$172,188University Of Alabama At Birmingham · R21 · FY2003 · NS
Assay Development for Drugs to Reduce Neuroinflammation
$172,188University Of Alabama At Birmingham · R21 · FY2004 · NS
Novel therapeutic targets in inflammatory neuropathies
$172,184Betty C Soliven · University Of Chicago · R21 · FY2006 · NS
REHABILITATION OF COGNITIVE SYMPTOMS IN MS
$172,125Kessler Medical Rehab Res &Educ Corp · R01 · FY2001 · HD
REHABILITATION OF COGNITIVE SYMPTOMS IN MS
$172,125Kessler Medical Rehab Res &Educ Corp · R01 · FY2000 · HD
REHABILITATION OF COGNITIVE SYMPTOMS IN MS
$172,125Kessler Medical Rehab Res &Educ Corp · R01 · FY2002 · HD
Axonal Protection by Myelin-Associated Glycoprotein (MAG)
$172,063Thien T Nguyen · Johns Hopkins University · K08 · FY2007 · NS
DNA-Based Biomarkers for Multiple Sclerosis
$172,031Victor V Levenson · Rush University Medical Center · R21 · FY2008 · NS
Dose and Treatment Selection in Clinical Trials
$171,915Ying Kuen Cheung · Columbia University Health Sciences · R01 · FY2008 · NS
Dose and Treatment Selection in Clinical Trials
$171,915Ying Kuen Cheung · Columbia University Health Sciences · R01 · FY2007 · NS
Technology platform for development of multi-component preservation solution
$171,838Allison Hubel · University Of Minnesota · R21 · FY2014 · EB
Seahorse XF-96 Analyzer for Non-Invasive Monitoring of Mitochondrial Function
$171,836Ahmet Hoke · Johns Hopkins University · S10 · FY2010 · RR
Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
$171,822Heather M Burke · University Of California, San Francisco · K08 · FY2009 · MH
Towards pratical Mapping of Complex White Matter Fiber Pathways by Disffusion-Wei
$171,719Ken Earl Sakaie · Cleveland Clinic Lerner Com-Cwru · R21 · FY2009 · NS